Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol SR vs IR in HFrEF
NCT03209180Phase 4Unknown
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Oct 2016
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of carvedilol in heart failure with reduced ejection fraction (HFrEF), sponsored by Seoul National University Bundang Hospital. Status: unknown.
02
Drugs
carvedilol
03
Conditions
heart failure with reduced ejection fraction (HFrEF)
Beyond the preview
Go deeper on NCT03209180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03209180.